Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Impact of Serum Potassium Levels on Prevalence and Risk Factors Associated With Management Strategies for Patients With Hyperkalaemia in Brazilian Clinical Settings: An Observational Study.

NCT07370194 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07370194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07370194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Impact of Serum Potassium Levels on Prevalence and Risk Factors Associated With Management Strategies for Patients With Hyperkalaemia in Brazilian Clinical Settings: An Observational Study.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
March 31, 2026
Completion date
September 30, 2026
Enrollment
6,215 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia